Cardiovascular Disease: A Shift from Diagnosis to Prevention

Cardiovascular diseases are the leading cause of death globally1

422.7 Million

The number of prevalent cases of cardiovascular disease around the world in 20152

31.7%

The proportion of deaths projected to be caused by cardiovascular disease by 20302


 
              

Troponin-I levels can vary – from levels that can help indicate a low risk, a moderate risk, or an elevated risk of a future cardiac event in people who otherwise appear healthy.

 
 
 
               

Dr. Gillian Murtagh discusses detecting cardiovascular disease. 

 

Identify Patients Who Are at Risk With High Sensitive Troponin-I  

The apparently healthy population may not know they are at risk, but when identified early, heart disease can be prevented through lifestyle changes and medications3. Risk Stratification is a tool that aids in identifying patients who are potentially at risk of cardiovascular disease, including cardiovascular death, MI, coronary revascularization, heart failure, or ischemic stroke in asymptomatic individuals.

Abbott has launched the first CE-marked cardiac specific blood test that provides greater accuracy in identifying a person's risk of developing cardiac diseases in the future, compared to current prediction tools, even in people with no apparent signs or symptoms. With the ARCHITECT High Sensitive Troponin-I assay, physicians now have a tool, when used in conjunction with clinical and diagnostic findings, that can aid in earlier identification and intervention to prevent cardiac events4.

For in vitro diagnostic use only.

Contact an Abbott Representative to Discover More

  1. Cardiovascular Diseases Fact Sheet. World Health Organization, May 2017.  http://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
  2. The Global Burden of Diseases (GBD), Injuries, and Risk Factors 2015; Journal of the American College of Cardiology.
  3. Know the Facts about Heart Disease, Center for Disease Control.  https://www.cdc.gov/heartdisease/docs/ConsumerEd_HeartDisease.pdf
  4. ARCHITECT STAT High Sensitive Troponin-I Package Insert G97079R01, June 2018.

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

DO YOU WISH TO CONTINUE AND EXIT THE CORE LABORATORY WEBSITE?

Content is not under the control of corelaboratory.abbott.

Yes No